{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:02:50Z","timestamp":1789398170511,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T00:00:00Z","timestamp":1789344000000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Bethune-Puai Medical Research Fund","award":["PAYJ-023"],"award-info":[{"award-number":["PAYJ-023"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"DOI":"10.1186\/s13075-026-03851-5","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T23:04:51Z","timestamp":1782687891000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Identification of distinct subgroups in Chinese patients with Beh\u00e7et\u2019s syndrome via cluster analysis of immune cells and clinical features"],"prefix":"10.1186","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4073-006X","authenticated-orcid":false,"given":"Jiachen","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanzhao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiumei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaping","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4422-5485","authenticated-orcid":false,"given":"Zhanguo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1691-8372","authenticated-orcid":false,"given":"Tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"issue":"10431","key":"3851_CR1","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/s0140-6736(23)02629-6","volume":"403","author":"G Emmi","year":"2024","unstructured":"Emmi G, Bettiol A, Hatemi G, et al. Beh\u00e7et\u2019s syndrome[J]. Lancet. 2024;403(10431):1093\u2013108. https:\/\/doi.org\/10.1016\/s0140-6736(23)02629-6.","journal-title":"Lancet"},{"issue":"7","key":"3851_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMra2305712","volume":"390","author":"D Saadoun","year":"2024","unstructured":"Saadoun D, Bodaghi B, Cacoub P. Beh\u00e7et\u2019s Syndrome[J]. N Engl J Med. 2024;390(7):640\u201351. https:\/\/doi.org\/10.1056\/NEJMra2305712.","journal-title":"N Engl J Med"},{"issue":"10","key":"3851_CR3","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.55563\/clinexprheumatol\/fqao16","volume":"42","author":"G Hatemi","year":"2024","unstructured":"Hatemi G, Seyahi E, Fresko I, et al. Beh\u00e7et\u2019s syndrome: one year in review 2024[J]. Clin Exp Rheumatol. 2024;42(10):1999\u20132007. https:\/\/doi.org\/10.55563\/clinexprheumatol\/fqao16.","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"3851_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41572-021-00301-1","volume":"7","author":"Y Yazici","year":"2021","unstructured":"Yazici Y, Hatemi G, Bodaghi B, et al. Beh\u00e7et syndrome[J]. Nat Rev Dis Primers. 2021;7(1):67. https:\/\/doi.org\/10.1038\/s41572-021-00301-1.","journal-title":"Nat Rev Dis Primers"},{"key":"3851_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/rai2.12049","volume":"3","author":"H Ahsan","year":"2023","unstructured":"Ahsan H. Origins and history of autoimmunity\u2014A brief review. Rheumatol Autoimmun. 2023;3:9\u201314. https:\/\/doi.org\/10.1002\/rai2.12049.","journal-title":"Rheumatol Autoimmun"},{"key":"3851_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/rai2.12155","volume":"4","author":"M Pan","year":"2024","unstructured":"Pan M, Yang J, Jiang Z. Inflammasomes and their roles in autoimmune diseases. Rheumatol Autoimmun. 2024;4:197\u2013217. https:\/\/doi.org\/10.1002\/rai2.12155.","journal-title":"Rheumatol Autoimmun"},{"issue":"1","key":"3851_CR7","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1186\/s13075-022-02867-x","volume":"24","author":"M Okubo","year":"2022","unstructured":"Okubo M, Sumitomo S, Tsuchida Y, et al. Transcriptome analysis of immune cells from Beh\u00e7et\u2019s syndrome patients: the importance of IL-17-producing cells and antigen-presenting cells in the pathogenesis of Beh\u00e7et\u2019s syndrome[J]. Arthritis Res Ther. 2022;24(1):186. https:\/\/doi.org\/10.1186\/s13075-022-02867-x.","journal-title":"Arthritis Res Ther"},{"issue":"16","key":"3851_CR8","doi-asserted-by":"publisher","first-page":"e2411524","DOI":"10.1002\/advs.202411524","volume":"12","author":"Y Wu","year":"2025","unstructured":"Wu Y, Ning K, Huang Z, et al. NETs-CD44-IL-17A Feedback Loop Drives Th17-Mediated Inflammation in Beh\u00e7et\u2019s Uveitis[J]. Adv Sci (Weinh). 2025;12(16):e2411524. https:\/\/doi.org\/10.1002\/advs.202411524.","journal-title":"Adv Sci (Weinh)"},{"issue":"7","key":"3851_CR9","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s10067-015-2966-2","volume":"35","author":"J Shimizu","year":"2016","unstructured":"Shimizu J, Takai K, Takada E, et al. Possible association of proinflammatory cytokines including IL1\u03b2 and TNF\u03b1 with enhanced Th17 cell differentiation in patients with Behcet\u2019s disease[J]. Clin Rheumatol. 2016;35(7):1857\u201363. https:\/\/doi.org\/10.1007\/s10067-015-2966-2.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3851_CR10","doi-asserted-by":"publisher","first-page":"8055","DOI":"10.1002\/jcp.27576","volume":"234","author":"A Salmaninejad","year":"2019","unstructured":"Salmaninejad A, Zamani MR, Shabgah AG, et al. Beh\u00e7et\u2019s disease: an immunogenetic perspective[J]. J Cell Physiol. 2019;234(6):8055\u201374. https:\/\/doi.org\/10.1002\/jcp.27576.","journal-title":"J Cell Physiol"},{"issue":"4","key":"3851_CR11","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1002\/jcp.27207","volume":"234","author":"M Ahmadi","year":"2019","unstructured":"Ahmadi M, Yousefi M, Abbaspour-Aghdam S, et al. Disturbed Th17\/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet\u2019s disease[J]. J Cell Physiol. 2019;234(4):3985\u201394. https:\/\/doi.org\/10.1002\/jcp.27207.","journal-title":"J Cell Physiol"},{"issue":"1","key":"3851_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08923973.2023.2239490","volume":"46","author":"R Oubouchou","year":"2024","unstructured":"Oubouchou R, Djeraba ZAA, Kemikem Y, et al. Immunomodulatory effect of vitamin D supplementation on Beh\u00e7et\u2019s disease patients: effect on nitric oxide and Th17\/Treg cytokines production[J]. Immunopharmacol Immunotoxicol. 2024;46(1):1\u201310. https:\/\/doi.org\/10.1080\/08923973.2023.2239490.","journal-title":"Immunopharmacol Immunotoxicol"},{"issue":"1","key":"3851_CR13","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1093\/rheumatology\/keab253","volume":"61","author":"A Filleron","year":"2021","unstructured":"Filleron A, Tran TA, Hubert A, et al. Regulatory T cell\/Th17 balance in the pathogenesis of paediatric Beh\u00e7et disease[J]. Rheumatology (Oxford). 2021;61(1):422\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keab253.","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"3851_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.5021\/ad.2018.30.5.566","volume":"30","author":"SJ Yun","year":"2018","unstructured":"Yun SJ, Kim K, Lee ES, et al. The suppressive effect of butyrate and bromopyruvate on inflammatory cytokine production and short chain fatty acid receptor expression by blood mononuclear cells in patients with Beh\u00e7et\u2019s disease[J]. Ann Dermatol. 2018;30(5):566\u201374. https:\/\/doi.org\/10.5021\/ad.2018.30.5.566.","journal-title":"Ann Dermatol"},{"issue":"1","key":"3851_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/bor.0000000000000980","volume":"36","author":"U Ilgen","year":"2024","unstructured":"Ilgen U. Cluster analysis as a clinical and research tool in Beh\u00e7et\u2019s syndrome[J]. Curr Opin Rheumatol. 2024;36(1):3\u20138. https:\/\/doi.org\/10.1097\/bor.0000000000000980.","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"3851_CR16","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13075-021-02429-7","volume":"23","author":"J Zou","year":"2021","unstructured":"Zou J, Luo JF, Shen Y, et al. Cluster analysis of phenotypes of patients with Beh\u00e7et\u2019s syndrome: a large cohort study from a referral center in China[J]. Arthritis Res Ther. 2021;23(1):45. https:\/\/doi.org\/10.1186\/s13075-021-02429-7.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"3851_CR17","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1007\/s10067-024-06995-4","volume":"43","author":"CH She","year":"2024","unstructured":"She CH, Hu D, Zou J, et al. Clinical phenotypes of adult-onset Beh\u00e7et\u2019s syndrome: a comprehensive cross-sectional study in China[J]. Clin Rheumatol. 2024;43(7):2261\u201371. https:\/\/doi.org\/10.1007\/s10067-024-06995-4.","journal-title":"Clin Rheumatol"},{"issue":"6","key":"3851_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/rhu.0000000000001996","volume":"29","author":"E Oguz","year":"2023","unstructured":"Oguz E, Bekta\u015f M. Characteristics of patients with beh\u00e7et disease from the van province, eastern turkey: definition of disease clusters in a tertiary referral center[J]. J Clin Rheumatol. 2023;29(6):285\u201390. https:\/\/doi.org\/10.1097\/rhu.0000000000001996.","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"3851_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13075-020-02406-6","volume":"23","author":"Y Soejima","year":"2021","unstructured":"Soejima Y, Kirino Y, Takeno M, et al. Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Beh\u00e7et\u2019s disease in Japan[J]. Arthritis Res Ther. 2021;23(1):49. https:\/\/doi.org\/10.1186\/s13075-020-02406-6.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"3851_CR20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1007\/s12026-024-09498-1","volume":"72","author":"G K\u0131l\u0131\u00e7","year":"2024","unstructured":"K\u0131l\u0131\u00e7 G, K\u00f6r\u00fckl\u00fc KF, Kumcu MG, et al. Gender disparities in Beh\u00e7et\u2019s syndrome: identifying distinct phenotypes through cluster analysis[J]. Immunol Res. 2024;72(5):975\u201381. https:\/\/doi.org\/10.1007\/s12026-024-09498-1.","journal-title":"Immunol Res"},{"issue":"3","key":"3851_CR21","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/jdv.12107","volume":"28","author":"The International Criteria for Beh\u00e7et\u2019s Disease (ICBD)","year":"2014","unstructured":"The International Criteria for Beh\u00e7et\u2019s Disease (ICBD). a collaborative study of 27 countries on the sensitivity and specificity of the new criteria[J]. J Eur Acad Dermatol Venereol. 2014;28(3):338\u201347. https:\/\/doi.org\/10.1111\/jdv.12107.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"3851_CR22","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1093\/rheumatology\/38.8.728","volume":"38","author":"BB Bhakta","year":"1999","unstructured":"Bhakta BB, Brennan P, James TE, et al. Beh\u00e7et\u2019s disease: evaluation of a new instrument to measure clinical activity[J]. Rheumatol (Oxford). 1999;38(8):728\u201333. https:\/\/doi.org\/10.1093\/rheumatology\/38.8.728.","journal-title":"Rheumatol (Oxford)"},{"key":"3851_CR23","unstructured":"Krause I, Mader R, Sulkes J et al. Beh\u00e7et\u2019s disease in Israel: the influence of ethnic origin on disease expression and severity[J]. J Rheumatol. 2001;28(5):1033-6. \u00a0DOI."},{"key":"3851_CR24","doi-asserted-by":"publisher","unstructured":"Liu J, Yu X, Wang Z, et al. https:\/\/doi.org\/10.1016\/j.clim.2023.109241.","DOI":"10.1016\/j.clim.2023.109241"},{"key":"3851_CR25","doi-asserted-by":"publisher","unstructured":"Wang Z, Wang X, Liu W, et al. https:\/\/doi.org\/10.1016\/j.clim.2023.109298.","DOI":"10.1016\/j.clim.2023.109298"},{"key":"3851_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-026-01381-7","author":"A Bettiol","year":"2026","unstructured":"Bettiol A, Bertsias G, Bodaghi B, et al. Treat-to-target in Beh\u00e7et syndrome[J]. Nat Rev Rheumatol. 2026. https:\/\/doi.org\/10.1038\/s41584-026-01381-7.","journal-title":"Nat Rev Rheumatol"},{"key":"3851_CR27","doi-asserted-by":"crossref","unstructured":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International study group for Beh\u00e7et\u2019s Disease[J]. Lancet. 1990;335(8697):1078-80. \u00a0DOI.","DOI":"10.1016\/0140-6736(90)92643-V"},{"key":"3851_CR28","unstructured":"Arida A, Vaiopoulos G, Markomichelakis N et al. Are clusters of patients with distinct clinical expression present in Beh\u00e7et\u2019s disease?[J]. Clin Exp Rheumatol, 2009;27(2 Suppl 53):S48-51. \u00a0DOI."},{"issue":"5","key":"3851_CR29","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1093\/rheumatology\/ker428","volume":"51","author":"C Maldini","year":"2012","unstructured":"Maldini C, Lavalley MP, Cheminant M, et al. Relationships of HLA-B51 or B5 genotype with Behcet\u2019s disease clinical characteristics: systematic review and meta-analyses of observational studies[J]. Rheumatol (Oxford). 2012;51(5):887\u2013900. https:\/\/doi.org\/10.1093\/rheumatology\/ker428.","journal-title":"Rheumatol (Oxford)"},{"key":"3851_CR30","doi-asserted-by":"publisher","first-page":"1206959","DOI":"10.3389\/fimmu.2023.1206959","volume":"14","author":"S Lin","year":"2023","unstructured":"Lin S, Xu Z, Lin Z, et al. Advances in pathogenesis and treatment of ocular involvement in Behcet\u2019s disease[J]. Front Immunol. 2023;14:1206959. https:\/\/doi.org\/10.3389\/fimmu.2023.1206959.","journal-title":"Front Immunol"},{"issue":"49","key":"3851_CR31","doi-asserted-by":"publisher","first-page":"e5516","DOI":"10.1097\/md.0000000000005516","volume":"95","author":"G Emmi","year":"2016","unstructured":"Emmi G, Silvestri E, Bella CD, et al. Cytotoxic Th1 and Th17 cells infiltrate the intestinal mucosa of Behcet patients and exhibit high levels of TNF-\u03b1 in early phases of the disease[J]. Med (Baltim). 2016;95(49):e5516. https:\/\/doi.org\/10.1097\/md.0000000000005516.","journal-title":"Med (Baltim)"},{"issue":"26","key":"3851_CR32","doi-asserted-by":"publisher","first-page":"e2204289119","DOI":"10.1073\/pnas.2204289119","volume":"119","author":"W Zheng","year":"2022","unstructured":"Zheng W, Wang X, Liu J, et al. Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Beh\u00e7et\u2019s disease[J]. Proc Natl Acad Sci U S A. 2022;119(26):e2204289119. https:\/\/doi.org\/10.1073\/pnas.2204289119.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3851_CR33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s10238-024-01462-5","volume":"24","author":"J Li","year":"2024","unstructured":"Li J, Sun F, Li Y, et al. Profile of immunological biomarkers in Behcet\u2019s syndrome: a large-scale single-center real-world study[J]. Clin Exp Med. 2024;24(1):201. https:\/\/doi.org\/10.1007\/s10238-024-01462-5.","journal-title":"Clin Exp Med"},{"key":"3851_CR34","doi-asserted-by":"publisher","unstructured":"Rodr\u00edguez-Carrio J, Nucera V, Masala IF, et al. https:\/\/doi.org\/10.1016\/j.phrs.2021.105593.","DOI":"10.1016\/j.phrs.2021.105593"},{"issue":"10","key":"3851_CR35","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.1093\/rheumatology\/kead703","volume":"63","author":"J Shi","year":"2024","unstructured":"Shi J, Zhang M, Zhang L, et al. Shelterin dysfunction promotes CD4\u2009+\u2009T cell senescence in Beh\u00e7et\u2019s disease[J]. Rheumatol (Oxford). 2024;63(10):2819\u201327. https:\/\/doi.org\/10.1093\/rheumatology\/kead703.","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"3851_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2249.2011.04543.x","volume":"168","author":"J Shimizu","year":"2012","unstructured":"Shimizu J, Takai K, Fujiwara N, et al. Excessive CD4\u2009+\u2009T cells co-expressing interleukin-17 and interferon-\u03b3 in patients with Beh\u00e7et\u2019s disease[J]. Clin Exp Immunol. 2012;168(1):68\u201374. https:\/\/doi.org\/10.1111\/j.1365-2249.2011.04543.x.","journal-title":"Clin Exp Immunol"},{"key":"3851_CR37","doi-asserted-by":"publisher","unstructured":"Jang DI, Lee AH, Shin HY, et al. The Role of Tumor Necrosis Factor Alpha (TNF-\u03b1) in Autoimmune Disease and Current TNF-\u03b1 Inhibitors in Therapeutics[J]. Int J Mol Sci. 2021;22(5). https:\/\/doi.org\/10.3390\/ijms22052719.","DOI":"10.3390\/ijms22052719"},{"key":"3851_CR38","doi-asserted-by":"publisher","unstructured":"Zhong Z, Su G, Yang P,. https:\/\/doi.org\/10.1016\/j.preteyeres.2023.101216.","DOI":"10.1016\/j.preteyeres.2023.101216"},{"key":"3851_CR39","doi-asserted-by":"publisher","first-page":"175628482211166","DOI":"10.1177\/17562848221116666","volume":"15","author":"S Zhan","year":"2022","unstructured":"Zhan S, Liu C, Li N, et al. Anti-TNF-\u03b1 agents for refractory intestinal Beh\u00e7et\u2019s disease: case series and meta-analysis[J]. Th Adv Gastroenterol. 2022;15:17562848221116666. https:\/\/doi.org\/10.1177\/17562848221116666.","journal-title":"Th Adv Gastroenterol"},{"key":"3851_CR40","doi-asserted-by":"publisher","unstructured":"van der Houwen T, van Laar J. Beh\u04abet\u2019s Disease, and the Role of TNF-\u03b1 and TNF-\u03b1 Blockers[J]. Int J Mol Sci. 2020;21(9). https:\/\/doi.org\/10.3390\/ijms21093072.","DOI":"10.3390\/ijms21093072"},{"key":"3851_CR41","doi-asserted-by":"publisher","unstructured":"Wang Q, Wu S, Ye X, et al. https:\/\/doi.org\/10.1016\/j.jaut.2023.103055.","DOI":"10.1016\/j.jaut.2023.103055"},{"issue":"3","key":"3851_CR42","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.immuni.2024.02.001","volume":"57","author":"AN Shouse","year":"2024","unstructured":"Shouse AN, LaPorte KM, Malek TR. Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer[J]. Immunity. 2024;57(3):414\u201328. https:\/\/doi.org\/10.1016\/j.immuni.2024.02.001.","journal-title":"Immunity"},{"issue":"12","key":"3851_CR43","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1016\/j.jid.2022.06.016","volume":"142","author":"S Peru","year":"2022","unstructured":"Peru S, Prochazkova-Carlotti M, Cherrier F, et al. Cutaneous lymphocyte antigen is a potential therapeutic target in cutaneous T-cell lymphoma[J]. J Invest Dermatol. 2022;142(12):3243\u2013e325210. https:\/\/doi.org\/10.1016\/j.jid.2022.06.016.","journal-title":"J Invest Dermatol"},{"issue":"3","key":"3851_CR44","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/bmt.2010.127","volume":"46","author":"BG Engelhardt","year":"2011","unstructured":"Engelhardt BG, Jagasia M, Savani BN, et al. Regulatory T cell expression of CLA or \u03b1(4)\u03b2(7) and skin or gut acute GVHD outcomes[J]. Bone Marrow Transpl. 2011;46(3):436\u201342. https:\/\/doi.org\/10.1038\/bmt.2010.127.","journal-title":"Bone Marrow Transpl"},{"issue":"7","key":"3851_CR45","doi-asserted-by":"publisher","first-page":"4488","DOI":"10.4049\/jimmunol.177.7.4488","volume":"177","author":"K Hirahara","year":"2006","unstructured":"Hirahara K, Liu L, Clark RA, et al. The majority of human peripheral blood CD4\u2009+\u2009CD25highFoxp3+ regulatory T cells bear functional skin-homing receptors[J]. J Immunol. 2006;177(7):4488\u201394. https:\/\/doi.org\/10.4049\/jimmunol.177.7.4488.","journal-title":"J Immunol"},{"key":"3851_CR46","doi-asserted-by":"publisher","unstructured":"Hensel MT, Peng T, Cheng A, et al. Selective expression of CCR10 and CXCR3 by circulating human herpes simplex virus-specific CD8 T Cells[J]. J Virol. 2017;91(19). https:\/\/doi.org\/10.1128\/jvi.00810-17.","DOI":"10.1128\/jvi.00810-17"},{"issue":"5","key":"3851_CR47","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","volume":"184","author":"ND Mathewson","year":"2021","unstructured":"Mathewson ND, Ashenberg O, Tirosh I, et al. Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis[J]. Cell. 2021;184(5):1281\u2013e129826. https:\/\/doi.org\/10.1016\/j.cell.2021.01.022.","journal-title":"Cell"},{"issue":"8","key":"3851_CR48","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1002\/eji.201243296","volume":"43","author":"B Afzali","year":"2013","unstructured":"Afzali B, Mitchell PJ, Edozie FC, et al. CD161 expression characterizes a subpopulation of human regulatory T cells that produces IL-17 in a STAT3-dependent manner[J]. Eur J Immunol. 2013;43(8):2043\u201354. https:\/\/doi.org\/10.1002\/eji.201243296.","journal-title":"Eur J Immunol"},{"issue":"14","key":"3851_CR49","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1182\/blood-2012-08-443473","volume":"121","author":"AM Pesenacker","year":"2013","unstructured":"Pesenacker AM, Bending D, Ursu S, et al. CD161 defines the subset of FoxP3\u2009+\u2009T cells capable of producing proinflammatory cytokines[J]. Blood. 2013;121(14):2647\u201358. https:\/\/doi.org\/10.1182\/blood-2012-08-443473.","journal-title":"Blood"},{"issue":"4","key":"3851_CR50","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s10067-022-06445-z","volume":"42","author":"W Bian","year":"2023","unstructured":"Bian W, Li Y, Sun F, et al. Immune phenotype changes in IgG4-related disease: CD161\u2009+\u2009Treg and Foxp3\u2009+\u2009Treg[J]. Clin Rheumatol. 2023;42(4):1113\u201324. https:\/\/doi.org\/10.1007\/s10067-022-06445-z.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"3851_CR51","doi-asserted-by":"publisher","first-page":"20675","DOI":"10.1038\/s41598-022-24924-w","volume":"12","author":"JN Pouw","year":"2022","unstructured":"Pouw JN, Olde Nordkamp MAM, van Kempen T, et al. Regulatory T cells in psoriatic arthritis: an IL-17A-producing, Foxp3(int)CD161\u2009+\u2009ROR\u03b3t\u2009+\u2009ICOS\u2009+\u2009phenotype, that associates with the presence of ADAMTSL5 autoantibodies[J]. Sci Rep. 2022;12(1):20675. https:\/\/doi.org\/10.1038\/s41598-022-24924-w.","journal-title":"Sci Rep"},{"key":"3851_CR52","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3389\/fimmu.2017.00103","volume":"8","author":"CL Duurland","year":"2017","unstructured":"Duurland CL, Brown CC, O\u2019Shaughnessy RF, et al. CD161(+) Tconv and CD161(+) Treg Share a Transcriptional and Functional Phenotype despite Limited Overlap in TCR\u03b2 Repertoire[J]. Front Immunol. 2017;8:103. https:\/\/doi.org\/10.3389\/fimmu.2017.00103.","journal-title":"Front Immunol"},{"issue":"Suppl 3","key":"3851_CR53","doi-asserted-by":"publisher","first-page":"iii108","DOI":"10.1093\/rheumatology\/keaa086","volume":"59","author":"O Karadag","year":"2020","unstructured":"Karadag O, Bolek EC. Management of Behcet\u2019s syndrome[J]. Rheumatol (Oxford). 2020;59(Suppl 3):iii108\u201317. https:\/\/doi.org\/10.1093\/rheumatology\/keaa086.","journal-title":"Rheumatol (Oxford)"},{"key":"3851_CR54","unstructured":"Shugaiv E, T\u00fcz\u00fcn E, Mutlu M et al. Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Beh\u00e7et\u2019s disease with parenchymal involvement: presentation of four cases[J]. Clin Exp Rheumatol. 2011;29(4 Suppl 67):S64-7. \u00a0DOI."},{"key":"3851_CR55","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.3389\/fimmu.2019.02830","volume":"10","author":"A Bettiol","year":"2019","unstructured":"Bettiol A, Hatemi G, Vannozzi L, et al. Treating the different phenotypes of Beh\u00e7et\u2019s syndrome[J]. Front Immunol. 2019;10:2830. https:\/\/doi.org\/10.3389\/fimmu.2019.02830.","journal-title":"Front Immunol"},{"issue":"6","key":"3851_CR56","doi-asserted-by":"publisher","first-page":"e0305355","DOI":"10.1371\/journal.pone.0305355","volume":"19","author":"F Teng","year":"2024","unstructured":"Teng F, Jin Q. Evaluation of cytokine expressions in patients with recurrent aphthous stomatitis: a systematic review and meta-analysis[J]. PLoS ONE. 2024;19(6):e0305355. https:\/\/doi.org\/10.1371\/journal.pone.0305355.","journal-title":"PLoS ONE"},{"issue":"2","key":"3851_CR57","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1007\/s00784-024-05531-7","volume":"28","author":"W Wei","year":"2024","unstructured":"Wei W, Deng Y, Wang Y, et al. Dynamic salivary cytokine profile of recurrent aphthous stomatitis patients in thalidomide maintenance treatment[J]. Clin Oral Investig. 2024;28(2):140. https:\/\/doi.org\/10.1007\/s00784-024-05531-7.","journal-title":"Clin Oral Investig"},{"key":"3851_CR58","doi-asserted-by":"publisher","first-page":"1609740","DOI":"10.3389\/fimmu.2025.1609740","volume":"16","author":"C Calvi\u00f1o-Su\u00e1rez","year":"2025","unstructured":"Calvi\u00f1o-Su\u00e1rez C, Dur\u00e1n-Rub\u00ed M, Brea J, et al. Exploration of JAK\/STAT pathway activation in ulcerative colitis reveals sex-dependent activation of JAK2\/STAT3 in the inflammatory response[J]. Front Immunol. 2025;16:1609740. https:\/\/doi.org\/10.3389\/fimmu.2025.1609740.","journal-title":"Front Immunol"},{"issue":"5","key":"3851_CR59","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1182\/blood-2011-12-396648","volume":"120","author":"S Pallikkuth","year":"2012","unstructured":"Pallikkuth S, Parmigiani A, Silva SY, et al. Impaired peripheral blood T-follicular helper cell function in HIV-infected nonresponders to the 2009 H1N1\/09 vaccine[J]. Blood. 2012;120(5):985\u201393. https:\/\/doi.org\/10.1182\/blood-2011-12-396648.","journal-title":"Blood"},{"issue":"2","key":"3851_CR60","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41584-022-00880-7","volume":"19","author":"A Bettiol","year":"2023","unstructured":"Bettiol A, Alibaz-Oner F, Direskeneli H, et al. Vascular Beh\u00e7et syndrome: from pathogenesis to treatment[J]. Nat Rev Rheumatol. 2023;19(2):111\u201326. https:\/\/doi.org\/10.1038\/s41584-022-00880-7.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"3851_CR61","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1160\/th14-02-0174","volume":"112","author":"PR Kapopara","year":"2014","unstructured":"Kapopara PR, von Felden J, Soehnlein O, et al. Deficiency of MAPK-activated protein kinase 2 (MK2) prevents adverse remodelling and promotes endothelial healing after arterial injury[J]. Thromb Haemost. 2014;112(6):1264\u201376. https:\/\/doi.org\/10.1160\/th14-02-0174.","journal-title":"Thromb Haemost"},{"issue":"10","key":"3851_CR62","doi-asserted-by":"publisher","first-page":"4910","DOI":"10.1093\/rheumatology\/keab052","volume":"60","author":"KM Verrou","year":"2021","unstructured":"Verrou KM, Vlachogiannis NI, Ampatziadis-Michailidis G, et al. Distinct transcriptional profile of blood mononuclear cells in Beh\u00e7et\u2019s disease: insights into the central role of neutrophil chemotaxis[J]. Rheumatol (Oxford). 2021;60(10):4910\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keab052.","journal-title":"Rheumatol (Oxford)"},{"issue":"1","key":"3851_CR63","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13075-022-02938-z","volume":"24","author":"X Wu","year":"2022","unstructured":"Wu X, Wang Z, Shi J, et al. Macrophage polarization toward M1 phenotype through NF-\u03baB signaling in patients with Beh\u00e7et\u2019s disease[J]. Arthritis Res Ther. 2022;24(1):249. https:\/\/doi.org\/10.1186\/s13075-022-02938-z.","journal-title":"Arthritis Res Ther"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-026-03851-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03851-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-026-03851-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:03:47Z","timestamp":1789394627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13075-026-03851-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3851"],"URL":"https:\/\/doi.org\/10.1186\/s13075-026-03851-5","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"assertion":[{"value":"15 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study complied with the Declaration of Helsinki and was approved by the hospital\u2019s Ethics Committee (Approval No. 2023PHB163-001). Written informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors have read and approved the final manuscript and consent to its publication.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"169"}}